Network origin in Valérie Autier first degree
Entity | Entity type | Industry | |
---|---|---|---|
Metabrain Research SAS
Metabrain Research SAS BiotechnologyHealth Technology Metabrain Research SAS provides contract research and research collaboration services. The firm offers metabolic disease research and drug discovery services for metabolic disorders including diabetes and obesity. The company was founded by Valérie Autier, Micheline Kergoat, Franck Lepifre and Christine Charon in March 2009 and is headquartered in Chilly-Mazarin, France.
2
| Private Company | Biotechnology | 2 |
Kymo Therapeutics Ltd.
Kymo Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kymo Therapeutics Ltd. develops and commercializes therapeutic products . The company was founded on May 23, 2016 and is headquartered in Hatfield, the United Kingdom.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Valérie Autier via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Aravis AG
Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland. | Investment Managers | Private Equity Investor | |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
ELSALYS BIOTECH | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Inception IBD, Inc.
Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder | |
University of Sherbrooke | College/University | Doctorate Degree | |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Financial Conglomerates | Chairman |
Statistics
International
France | 4 |
Switzerland | 2 |
United States | 2 |
Canada | 2 |
Sectoral
Finance | 3 |
Commercial Services | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Operational
Director/Board Member | 4 |
Founder | 3 |
Corporate Officer/Principal | 2 |
Private Equity Investor | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Most connected contacts
Insiders | |
---|---|
Mizrahi Jacques | 7 |
Franck Lepifre | 1 |
Christine Charon | 1 |
Robert Narquizian | 1 |
- Stock Market
- Insiders
- Valérie Autier
- Company connections